<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) in the United States: Clinical manifestations, evaluation, and diagnosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) in the United States: Clinical manifestations, evaluation, and diagnosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) in the United States: Clinical manifestations, evaluation, and diagnosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michelle Ruha, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Meghan Spyres, MD, FACMT</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel F Danzl, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andrew Stolbach, MD, MPH, FAACT, FACMT, FACEP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Ganetsky, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Mar 20, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>The clinical manifestations, evaluation, and diagnosis of venomous Crotalinae (rattlesnake, water moccasin [cottonmouth], or copperhead) snakebites are reviewed here. The principles of management of Crotalinae snakebites, coral snakebites, and snakebites outside the United States are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/121865.html" rel="external">"Bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) in the United States: Management"</a> and  <a class="medical medical_review" href="/z/d/html/6599.html" rel="external">"Evaluation and management of coral snakebites"</a> and  <a class="medical medical_review" href="/z/d/html/6594.html" rel="external">"Snakebites worldwide: Clinical manifestations and diagnosis"</a>.)</p><p class="headingAnchor" id="H628739"><span class="h1">TERMINOLOGY</span><span class="headingEndMark"> — </span>Rattlesnakes (<em>Crotalus</em> and <em>Sistrurus</em> species), water moccasins (cottonmouths, <em>Agkistrodon piscivorus</em>), and copperheads (<em>Agkistrodon contortrix</em>)<em> </em>are members of the family Viperidae, subfamily Crotalinae, and constitute the most common medically important snakes in North America  (<a class="graphic graphic_table graphicRef122086" href="/z/d/graphic/122086.html" rel="external">table 1</a>). These snakes are also commonly called "pit vipers," a name that refers to the heat-sensing pit located behind the nostrils.</p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Approximately 5000 venomous snakebites are reported to the American Association of Poison Control Centers annually [<a href="#rid1">1</a>]. Among venomous snakes, copperheads, rattlesnakes, and water moccasins (cottonmouths) account for the most snakebites in the United States; copperhead snakes are responsible for nearly half of all venomous snakebites in the United States [<a href="#rid2">2-4</a>]. These snakes are also found in southern Canada and northern Mexico. Elapids (coral snakes) and imported exotic snakes cause a much smaller number of envenomations (approximately 100 snakebites annually) [<a href="#rid3">3,5</a>].</p><p>Snakebites occur more frequently in the summer months when snakes are most active [<a href="#rid5">5</a>]. Copperhead and rattlesnake bites are more frequent than cottonmouth bites. Copperhead bites happen more commonly in the southeastern United States and rattlesnake bites in the west. Southern and western states with warmer climates, including Texas, Oklahoma, Florida, California, Arizona, Louisiana, Georgia, and North Carolina, report the greatest number of venomous snakebites [<a href="#rid5">5</a>].</p><p>Among all patients, snakebites to the lower extremity are most common [<a href="#rid2">2,3</a>]. However, among men, bites to the upper extremity predominate. Clinical effects after Crotalinae envenomation are generally more severe in patients with rattlesnake envenomation than from copperhead and cottonmouth species. However, fatalities are rare for any snakebite in the United States [<a href="#rid5">5</a>].</p><p class="headingAnchor" id="H3"><span class="h1">APPEARANCE AND GEOGRAPHICAL DISTRIBUTION</span><span class="headingEndMark"> — </span>Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], and copperheads) are members of the Viperidae family and are commonly referred to as "pit vipers" [<a href="#rid6">6</a>]. They have folding, long fangs; triangular heads with an abrupt transition to the body; and numerous smaller scales on the head. Pit vipers also have heat-sensing pits towards the front of the head (for infrared "vision") and elliptical pupils. Many nonvenomous snakes are effective mimics.</p><p>Crotalinae snakes are widely distributed in the United States:</p><p class="bulletIndent1"><span class="glyph">●</span>Rattlesnake (<em>Crotalus</em> and <em>Sistrurus</em> species) – Rattlesnakes  (<a class="graphic graphic_picture graphicRef122492" href="/z/d/graphic/122492.html" rel="external">picture 1</a>) live throughout the continental United States; they are native to all states except Alaska, Hawaii, and Maine.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Water moccasin (<em>Agkistrodon piscivorus</em>) – Water moccasins (cottonmouths)  (<a class="graphic graphic_picture graphicRef122490" href="/z/d/graphic/122490.html" rel="external">picture 2</a>) are found in the southeastern and southern United States, from Virginia to Florida and west to Texas.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Copperhead (<em>Agkistrodon contortrix</em>) – Copperheads  (<a class="graphic graphic_picture graphicRef122491" href="/z/d/graphic/122491.html" rel="external">picture 3</a>) are common in the eastern half of the continental United States, extending as far west as eastern Missouri, Arkansas, and Oklahoma and extending north to south from Massachusetts to Texas.</p><p></p><p>Climate change has resulted in observable geographic and seasonal changes in United States snakebite incidence patterns in some regions [<a href="#rid7">7</a>]. For maps of geographic distributions for snake species or specific snakes by genus, species, and subspecies, refer to the <a class="external" href="/external-redirect?target_url=http%3A%2F%2Fwww.toxinology.com%2Ffusebox.cfm%3Ffuseaction%3Dmain.snakes.search&amp;token=9y6034F3W7g5kU3AdmbGHBLpSj%2FhV0hW4%2BGHXAI%2Fs55orSO4XFFmogRHFs5O%2F4dhZ%2BDeF%2BR%2BByirc88cbaKrbFS6CrpkhZ3OpKAyyrDlm2Y%3D&amp;TOPIC_ID=6595" target="_blank">Toxinology snake search</a>.</p><p class="headingAnchor" id="H3774799661"><span class="h1">VENOM PROPERTIES</span><span class="headingEndMark"> — </span>Crotalinae venom is a complex mixture of over 50 types of toxic compounds including phospholipase A<sub>2</sub> (PLA<sub>2</sub>), serine proteases, and metalloproteinases [<a href="#rid8">8</a>]. Venom composition varies across and within snake species and appears to be strongly impacted by geography, environmental conditions, including seasonal variation and prey preferences related to environment as well as snake size and location [<a href="#rid9">9</a>].</p><p>Crotalinae venom toxins produce a variety of effects after envenomation:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Local tissue and muscle damage</strong> – Local toxic effects are seen in 90 to 100 percent of Crotalinae envenomations [<a href="#rid3">3,10</a>]. Within one hour of envenomation, enzymatic action on the extracellular matrix, the vascular endothelium, and the basement membrane causes tissue swelling, redness, and pain. Progressive swelling involving the entire extremity and/or tissue necrosis indicates a severe envenomation with potential for significant tissue loss and, for bites to the fingers or toes, autoamputation [<a href="#rid4">4</a>].</p><p></p><p class="bulletIndent1">Myotoxic compounds have been identified in some rattlesnake species [<a href="#rid5">5</a>]. However, rhabdomyolysis occurs in &lt;10 percent of Crotalinae snake envenomations. It has been most commonly described after bites by the canebrake rattlesnake (<em>Crotalus horridus atricaudatus </em>[no longer recognized as a subspecies of the Timber rattlesnake, <em>Crotalus horridus</em>]) and the Mohave rattlesnake (<em>Crotalus scutulatus</em>) [<a href="#rid11">11-13</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemotoxicity</strong> – Hemotoxicity occurs in up to 40 percent of rattlesnake envenomations and up to 15 percent of copperhead envenomations and is characterized by prolonged prothrombin time (PT), hypofibrinogenemia, and thrombocytopenia [<a href="#rid3">3,14</a>]. Frank bleeding occurs in a minority of patients, and life-threatening hemorrhage is rare [<a href="#rid15">15</a>]. Hypofibrinogenemia and thrombocytopenia occur as a result of the actions of multiple venom components, including thrombin-like enzymes, metalloproteinases, PLA<sub>2</sub>, disintegrins and C-type lectin-like proteins [<a href="#rid16">16</a>]. This pathophysiology is in contrast to true disseminated intravascular coagulation (DIC), where fibrinolysis is activated by increased levels of endogenous thrombin.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cardiovascular</strong> – Hypotension may arise from a variety of venom effects such as increased capillary permeability, vasodilation, and bleeding [<a href="#rid4">4</a>]. </p><p></p><p class="bulletIndent1">Angioedema, hypotension, and cardiovascular collapse may arise from anaphylactic or anaphylactoid reactions but are uncommon (&lt;1 percent of envenomations). Factors that may increase the risk of anaphylaxis to venom include previous snakebites by similar species, ingestion of rattlesnake meat, or snake handling [<a href="#rid4">4,10,17,18</a>]. Several components of venom, including bradykinin potentiating peptides and phospholipases A2, may lead to hypotension [<a href="#rid19">19,20</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neurotoxicity</strong> – Acute neurotoxicity is uncommon after most North American snakebites [<a href="#rid4">4</a>]. Neurotoxic effects include perioral and extremity paresthesias, bulbar abnormalities (eg, dysarthria, dysphagia), and myokymia (rippling muscle movement often seen in the face and proximal extremity muscle groups; frequently characterized as fasciculations in snakebite literature). Antivenom is indicated for neurotoxicity, but both success and failure have been reported [<a href="#rid21">21-23</a>].</p><p></p><p class="bulletIndent1">It is not clear why myokymia occurs, but interaction of venom components with calcium binding sites on peripheral nerves has been hypothesized [<a href="#rid24">24</a>]. Myokymia or fasciculations are most often reported after bites by the Timber rattlesnak<em>e (Crotalus horridus</em>], but also occur after envenomation by many western rattlesnake species, including the Mohav<em>e (Crotalus scutulatus</em>), Grand Canyo<em>n (Crotalus lutosus abyssus</em>), Southern Pacifi<em>c (Crotalus helleri</em>), Midget Fade<em>d (Crotalus concolor</em>), and Western diamondbac<em>k (Crotalus atrox</em>) rattlesnakes [<a href="#rid23">23-27</a>]. Myokymia may interfere with swallowing and cause upper airway obstruction or ataxia such that victims describe difficulty walking.</p><p></p><p class="bulletIndent1">Severe weakness, bulbar abnormalities, and paralysis after rattlesnake bites are very uncommon but may result from envenomation by some populations of the Mohave rattlesnak<em>e </em>(<em>Crotalus scutulatus</em>) and the Southern Pacific rattlesnake (<em>Crotalus helleri) </em>[<a href="#rid23">23</a>]<em>.</em> In certain locales, the venom of these snakes may possess Mojave toxin, a PLA<sub>2</sub> that acts presynaptically to inhibit release of acetylcholine [<a href="#rid4">4,22,28,29</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other systemic effects</strong> – Crotalinae envenomation may also lead to nausea, vomiting, diarrhea, and metallic taste [<a href="#rid3">3,4</a>].</p><p></p><p class="headingAnchor" id="H468485165"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Clinical findings of Crotalinae envenomation (which by definition excludes so-called "dry bites") vary by geography, the specific snake species, degree, and depth of envenomation. Envenomation tends to evolve clinically over time and more dramatically the longer treatment is delayed. Estimated frequencies include [<a href="#rid3">3,4</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Local swelling, erythema, and pain: 90 to 100 percent.</p><p class="bulletIndent1"><span class="glyph">●</span>Thrombocytopenia and/or coagulopathy: Up to 40 percent.</p><p class="bulletIndent1"><span class="glyph">●</span>Vomiting: Up to 20 percent.</p><p class="bulletIndent1"><span class="glyph">●</span>Bleeding (typically not life-threatening): Up to 8 percent.</p><p class="bulletIndent1"><span class="glyph">●</span>Neurotoxicity: Up to 8 percent (primarily after rattlesnake bites, includes myokymia [rippling muscle movement, often seen in the face]).</p><p class="bulletIndent1"><span class="glyph">●</span>Tachycardia and/or hypotension: Up to 6 percent (primarily after rattlesnake bites).</p><p class="bulletIndent1"><span class="glyph">●</span>Rhabdomyolysis: &lt;5 percent.</p><p class="bulletIndent1"><span class="glyph">●</span>Angioedema (allergic or anaphylactoid reaction): 1 to 2 percent.</p><p class="bulletIndent1"><span class="glyph">●</span>Weakness, paralysis: Rare for Crotalinae snakebites overall, but described in 50 percent of Mojave rattlesnake bites in one 1997 report from southern California [<a href="#rid30">30</a>].</p><p></p><p>Presenting features can also be organized as local versus systemic signs and symptoms:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Local</strong> – The bite wound is characterized by two puncture wounds (fang marks)  (<a class="graphic graphic_picture graphicRef122493" href="/z/d/graphic/122493.html" rel="external">picture 4</a> and <a class="graphic graphic_picture graphicRef122494" href="/z/d/graphic/122494.html" rel="external">picture 5</a>); the distance between the wounds varies according to the size of the snake [<a href="#rid31">31</a>]. One puncture wound may also be seen and should <strong>not</strong> be dismissed as a sting or assumed to be a nonvenomous bite  (<a class="graphic graphic_picture graphicRef122500" href="/z/d/graphic/122500.html" rel="external">picture 6</a>).</p><p></p><p class="bulletIndent1">Crotalinae envenomation produces pain, swelling  (<a class="graphic graphic_picture graphicRef122497" href="/z/d/graphic/122497.html" rel="external">picture 7</a> and <a class="graphic graphic_picture graphicRef73921" href="/z/d/graphic/73921.html" rel="external">picture 8</a>), ecchymoses  (<a class="graphic graphic_picture graphicRef122496" href="/z/d/graphic/122496.html" rel="external">picture 9</a>), and erythema at the bite site. These findings typically develop within an hour of the bite but can be slower in onset, occasionally taking eight hours or more to become apparent. Proximal spread of swelling as well as tenderness along lymphatic pathways suggests progressive toxicity [<a href="#rid3">3,10</a>]. When an extremity is elevated, swelling may move proximally due to gravity, and continued swelling distal to the bite will aid in determining progression of envenomation.</p><p></p><p class="bulletIndent1">Hemorrhagic bullae  (<a class="graphic graphic_picture graphicRef122495" href="/z/d/graphic/122495.html" rel="external">picture 10</a>) develop at the bite site in up to 40 percent of patients with bites to upper extremities  (<a class="graphic graphic_picture graphicRef122498" href="/z/d/graphic/122498.html" rel="external">picture 11</a>) [<a href="#rid32">32</a>].</p><p></p><p class="bulletIndent1">"Dry bites" (in which no venom was injected) occur in approximately 25 percent of Crotalinae snakebites in the United States and show only minimal local irritation [<a href="#rid1">1,6,10</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic</strong> – Nausea, vomiting, tachycardia, paresthesias, hypotension, and dizziness suggest more severe envenomation [<a href="#rid1">1,3,4,10</a>]. Bleeding, hypotension, fasciculations, weakness, and altered mental status signal a potentially life-threatening envenomation.</p><p></p><p class="headingAnchor" id="H503795158"><span class="h1">EVALUATION</span><span class="headingEndMark"> — </span>Identifying signs of envenomation and indications for antivenom will guide further management  (<a class="graphic graphic_algorithm graphicRef138360" href="/z/d/graphic/138360.html" rel="external">algorithm 1</a>). Clinical findings are likely to progress over time and may progress slowly; even very minor findings at presentation may develop into significant ones over time. Thus, any patient with a possible Crotalinae snakebite warrants emergency evaluation and observation for at least 8 to 12 hours, even in the absence of symptoms [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/z/d/html/121865.html" rel="external">"Bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) in the United States: Management"</a>.)</p><p class="headingAnchor" id="H2265263489"><span class="h2">Stabilization</span><span class="headingEndMark"> — </span>Prior to evaluation, emergency stabilization of airway, breathing, and circulation should occur as needed.</p><p>Emergency management of shock followed by timely antivenom administration to patients with moderate or severe envenomation comprise the most common actions needed when stabilizing patients with Crotalinae snakebites. Patients with myokymia, muscle weakness, angioedema, or bites to the face or neck warrant close airway assessment and may require emergency endotracheal intubation. (See  <a class="medical medical_review" href="/z/d/html/121865.html" rel="external">"Bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) in the United States: Management"</a>.)</p><p class="headingAnchor" id="H604616927"><span class="h2">History</span><span class="headingEndMark"> — </span>When a snakebite is reported or suspected, key information to determine includes:</p><p class="bulletIndent1"><span class="glyph">●</span>Where and when the bite occurred</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A description of the snake, whenever possible</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>How the bite occurred and whether there was more than one bite</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Any signs or symptoms and the timing of onset</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Initial treatment and first aid that was provided, including timing of first aid (see  <a class="medical medical_review" href="/z/d/html/121865.html" rel="external">"Bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) in the United States: Management", section on 'First aid'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Any recent ethanol or recreational drug use that may modify the patient's presentation</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Pertinent past medical history, such as current medications (especially anticoagulants or beta blockers), any prior snakebites for which antivenom was given, or allergy to animals used in antivenom production (eg, horses or sheep)</p><p></p><p>In most cases, the Crotalinae snakebite is immediately felt. However, children may occasionally present with irritability, shock, or sudden collapse without any reported snakebite.</p><p>Although Crotalinae envenomations most frequently present with local tissue effects, the signs and symptoms of a snakebite can be nonspecific and frequently may be difficult to differentiate from manifestations of anxiety and emotional disturbance caused by the bite. Findings such as nausea, vomiting, abdominal pain, and diarrhea may be the first symptoms of systemic envenomation and warrant close assessment for onset of angioedema, hypotension, or shock.</p><p>Symptoms also vary according to the venom characteristics of the biting snake. In general, rattlesnake envenomations cause more severe signs and symptoms than water moccasins (cottonmouths) or copperheads [<a href="#rid5">5</a>]. Copperheads usually cause only limited local tissue swelling and pain with no systemic symptoms [<a href="#rid14">14,33</a>]. However, the identity of the offending snake is often unknown. In addition, bites from any of the Crotalinae snakes (rattlesnake, water moccasin [cottonmouth], or copperhead) may cause clinically significant findings. (See <a class="local">'Clinical manifestations'</a> above.)</p><p>Weakness after a snakebite in the appropriate region suggests a bite by the Mohave rattlesnake (<em>Crotalus scutulatus</em>), or, less commonly, the Southern Pacific rattlesnake (<em>Crotalus helleri</em>) [<a href="#rid28">28,30</a>]. (See <a class="local">'Venom properties'</a> above.)</p><p class="headingAnchor" id="H2919739624"><span class="h2">Physical examination</span><span class="headingEndMark"> — </span>Findings on physical examination vary based on many factors related to both the snake and the patient and may evolve over time:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vital signs</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In the calm patient, envenomation without systemic toxicity typically presents with normal or near-normal vital signs.</p><p class="bulletIndent2"><span class="glyph">•</span>Mild tachycardia or tachypnea may reflect anxiety or pain, or represent early findings of systemic envenomation.</p><p class="bulletIndent2"><span class="glyph">•</span>Marked tachycardia, tachypnea, or hypotension often indicates systemic toxicity. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Systemic findings</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Cardiovascular</strong> – Tachycardia and findings of shock, including hypotension and/or poor tissue perfusion (eg, prolonged capillary refill time, altered mental status, and decreased urine output) signify severe Crotalinae envenomation. Causes include venom-induced vasodilation and/or hypovolemia from bleeding or "third spacing" of fluids into the bitten limb. These patients warrant emergency stabilization. (See  <a class="medical medical_review" href="/z/d/html/121865.html" rel="external">"Bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) in the United States: Management", section on 'Initial stabilization'</a>.)</p><p></p><p class="bulletIndent2">Angioedema, hypotension, and cardiovascular collapse may arise from anaphylactic or anaphylactoid reactions. Individuals with any one of the following may be at increased risk for anaphylaxis to venom: snakebites by similar species, ingestion of rattlesnake meat, or snake handling [<a href="#rid4">4,10,17,18</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hemotoxicity</strong> – Signs of overt bleeding should be sought and usually present as low-grade bleeding from gums, oozing from needle puncture sites, epistaxis, or petechiae. Bleeding is most common when severe venom-induced thrombocytopenia and coagulopathy coexist, but risk is also increased in patients using anticoagulant or antiplatelet medications [<a href="#rid15">15</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Tissue and muscle toxicity</strong> – Most patients with Crotalinae envenomation have local tissue swelling surrounding the bite site, as described below.</p><p></p><p class="bulletIndent2">Less commonly, muscle pain on palpation or with muscle use, muscle weakness, and dark urine may indicate the presence of rhabdomyolysis. Early findings of rhabdomyolysis may be subtle and frequently require measurement of serum creatine kinase and urine studies for confirmation. (See <a class="local">'Ancillary studies'</a> below.)</p><p></p><p class="bulletIndent2">Although rare after a Crotalinae snakebite, compartment syndrome may occur if marked extremity swelling or direct envenomation of a muscle compartment occurs. (See  <a class="medical medical_review" href="/z/d/html/121865.html" rel="external">"Bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) in the United States: Management", section on 'Elevated tissue pressures'</a>.)</p><p></p><p class="bulletIndent2">Findings of compartment syndrome can significantly overlap with local and systemic effects of envenomation and include (see  <a class="medical medical_review" href="/z/d/html/358.html" rel="external">"Acute compartment syndrome of the extremities", section on 'Clinical features'</a>):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Pain upon passive stretching of the muscle (although this can also be caused by venom-induced myolysis)</p><p class="bulletIndent3"><span class="glyph">-</span>Marked burning or aching pain that is not controlled despite parenteral opioid analgesia (eg, <a class="drug drug_general" data-topicid="9788" href="/z/d/drug information/9788.html" rel="external">morphine</a>)</p><p class="bulletIndent3"><span class="glyph">-</span>Paresthesias and/or diminished sensation</p><p class="bulletIndent3"><span class="glyph">-</span>Muscle weakness (although this can also be caused by venom-induced myolysis or neurotoxicity)</p><p class="bulletIndent3"><span class="glyph">-</span>Tense compartment with a wooden feeling to palpation (late sign)</p><p class="bulletIndent3"><span class="glyph">-</span>Pallor and/or pulselessness (late sign)</p><p></p><p class="bulletIndent2">Direct measurement of compartment pressures are essential to verify the clinical impression. (See  <a class="medical medical_review" href="/z/d/html/358.html" rel="external">"Acute compartment syndrome of the extremities", section on 'Measurement of compartment pressures'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neurotoxicity</strong> – Weakness may occur after bites by some populations of the Mohave rattlesnake (<em>Crotalus scutulatus</em>) or Southern Pacific rattlesnake (<em>Crotalus helleri</em>). Myokymia (rippling muscle movement often seen in the face) is a more common neurologic manifestation that has been associated with bites by several species of rattlesnakes, including the Timber rattlesnake (<em>Crotalus horridus</em>), the Mohave rattlesnake (<em>Crotalus scutulatus</em>), the Grand Canyon rattlesnake (<em>Crotalus lutosus abyssus</em>), the Southern Pacific rattlesnake (<em>Crotalus helleri</em>), the Midget Faded rattlesnake (<em>Crotalus concolor</em>), and the Western diamondback rattlesnake (<em>Crotalus atrox</em>) [<a href="#rid24">24-27</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Wound site</strong> – The clinician should examine the bite site and surrounding region for the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Presence of fang marks (eg, single or multiple punctures or scratches; fang marks may be difficult to visualize in some species)  (<a class="graphic graphic_picture graphicRef122493" href="/z/d/graphic/122493.html" rel="external">picture 4</a> and <a class="graphic graphic_picture graphicRef122494" href="/z/d/graphic/122494.html" rel="external">picture 5</a> and <a class="graphic graphic_picture graphicRef122500" href="/z/d/graphic/122500.html" rel="external">picture 6</a> and <a class="graphic graphic_picture graphicRef122499" href="/z/d/graphic/122499.html" rel="external">picture 12</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Local evidence of envenomation including redness, swelling, blistering, ecchymosis, persistent blood ooze, or tissue necrosis  (<a class="graphic graphic_picture graphicRef122497" href="/z/d/graphic/122497.html" rel="external">picture 7</a> and <a class="graphic graphic_picture graphicRef73921" href="/z/d/graphic/73921.html" rel="external">picture 8</a> and <a class="graphic graphic_picture graphicRef122496" href="/z/d/graphic/122496.html" rel="external">picture 9</a> and <a class="graphic graphic_picture graphicRef122495" href="/z/d/graphic/122495.html" rel="external">picture 10</a> and <a class="graphic graphic_picture graphicRef122498" href="/z/d/graphic/122498.html" rel="external">picture 11</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Degree of swelling, using demarcation of the extent of swelling from the bite site for reference during repeated examinations  (<a class="graphic graphic_picture graphicRef122497" href="/z/d/graphic/122497.html" rel="external">picture 7</a>). If a leading edge of swelling is not evident, repeated measurement of extremity circumference both proximal and distal to the bite site may be used to determine if swelling is progressing over time.</p><p></p><p class="bulletIndent2">Swelling that progresses only proximally after elevation of the extremity does not alone represent progression of envenomation.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Swelling or tenderness of regional lymph nodes indicating venom spread.</p><p></p><p class="headingAnchor" id="H329643108"><span class="h2">Ancillary studies</span><span class="headingEndMark"> — </span>Evaluation for suspected Crotalinae envenomation (rattlesnake, water moccasin [cottonmouth], or copperhead bite) should include the following studies to assess for evidence of hematologic and muscle toxicity:</p><p class="bulletIndent1"><span class="glyph">●</span>Complete blood count</p><p class="bulletIndent1"><span class="glyph">●</span>Fibrinogen level</p><p class="bulletIndent1"><span class="glyph">●</span>Prothrombin time (PT) </p><p class="bulletIndent1"><span class="glyph">●</span>International normalized ratio (INR)</p><p></p><p>Patients with evidence of systemic toxicity should also have the following studies obtained: </p><p class="bulletIndent1"><span class="glyph">●</span>Serum creatine kinase (CK)</p><p class="bulletIndent1"><span class="glyph">●</span>Serum electrolytes, creatinine and blood urea nitrogen</p><p class="bulletIndent1"><span class="glyph">●</span>Chest radiograph</p><p class="bulletIndent1"><span class="glyph">●</span>Electrocardiogram (ECG)</p><p></p><p>Concern for compartment syndrome or neurotoxicity:</p><p class="bulletIndent1"><span class="glyph">●</span>Serum CK</p><p></p><p>If fibrinogen testing is not immediately available, a D-dimer or fibrin degradation products (fibrin split products [FSPs]) can be obtained, ideally at least four hours post-envenomation, to determine if fibrinogenolytic effects are occurring. Some experts routinely obtain D-dimer at four or more hours after a Crotalinae snakebite to identify patients whose initial labs do not show significant abnormalities, but who remain at risk for delayed hemotoxicity.</p><p>Presence of venom-induced thrombocytopenia or hypofibrinogenemia indicates an increased risk of postdischarge hematologic recurrence, although late hemotoxicity may also occur in patients without early platelet or fibrinogen abnormalities. (See  <a class="medical medical_review" href="/z/d/html/121865.html" rel="external">"Bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) in the United States: Management", section on 'Prevention of early recurrent toxicity'</a>.)</p><p>Hematologic toxicity (prolonged PT, thrombocytopenia, or hypofibrinogenemia) may not be apparent at presentation but can develop over several hours after the snakebite. Platelet count and fibrinogen levels should be repeated at regular intervals. If antivenom is given, they should be repeated one hour following administration to assess for control of hematological effects. Additional monitoring of hematologic toxicity depends upon patient response and specific antivenom given. The frequency of repeated measurements varies depending on the severity of the envenomation. (See  <a class="medical medical_review" href="/z/d/html/121865.html" rel="external">"Bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) in the United States: Management", section on 'Identification and treatment of late hemotoxicity'</a>.)</p><p class="headingAnchor" id="H891772226"><span class="h2">Reassessment</span><span class="headingEndMark"> — </span>Frequent, repeated examinations are important to ensure detection of all signs of Crotalinae snake envenomation and to identify serious and progressive local or systemic effects. All patients with a potentially toxic snakebite warrant frequent measurement of blood pressure and continuous cardiorespiratory and pulse oximetry monitoring.</p><p>Hematologic studies should also be repeated:</p><p class="bulletIndent1"><span class="glyph">●</span>Potential dry bite or minimal local findings – Repeat at least four hours after initial studies and at least eight hours after the bite occurred. If any decrease in platelets or fibrinogen occurs, even if the values remain within normal range, repeat again after at least another four hours. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Envenomation – Repeat one hour after each administration of antivenom. Recommendations for monitoring of late hematotoxicity after administration of Crotalidae polyvalent-immune Fab (ovine), brand name CroFab (FabAV), and Anavip are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/121865.html" rel="external">"Bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) in the United States: Management", section on 'Prevention of early recurrent toxicity'</a>.)</p><p></p><p class="headingAnchor" id="H2110305713"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) is usually straightforward because the bite is immediately felt and a snake is seen. The presence of fang marks  (<a class="graphic graphic_picture graphicRef122493" href="/z/d/graphic/122493.html" rel="external">picture 4</a> and <a class="graphic graphic_picture graphicRef122494" href="/z/d/graphic/122494.html" rel="external">picture 5</a> and <a class="graphic graphic_picture graphicRef122500" href="/z/d/graphic/122500.html" rel="external">picture 6</a> and <a class="graphic graphic_picture graphicRef122499" href="/z/d/graphic/122499.html" rel="external">picture 12</a>), pain, and local effects of swelling, ecchymosis, and blistering  (<a class="graphic graphic_picture graphicRef122497" href="/z/d/graphic/122497.html" rel="external">picture 7</a> and <a class="graphic graphic_picture graphicRef73921" href="/z/d/graphic/73921.html" rel="external">picture 8</a> and <a class="graphic graphic_picture graphicRef122496" href="/z/d/graphic/122496.html" rel="external">picture 9</a> and <a class="graphic graphic_picture graphicRef122495" href="/z/d/graphic/122495.html" rel="external">picture 10</a> and <a class="graphic graphic_picture graphicRef122498" href="/z/d/graphic/122498.html" rel="external">picture 11</a>), or evidence of systemic envenomation provide confirmation. (See <a class="local">'Clinical manifestations'</a> above.)</p><p>Snakebites may go unrecognized if they occur in young or unsupervised children or cause sudden collapse with unconsciousness in older children and adults. Thus, the clinician should maintain a high index of suspicion for a Crotalinae snakebite when evaluating presentations of abrupt onset of irritability (young children), unilateral extremity swelling, cardiovascular collapse, and/or neurologic impairment, especially in regions where venomous snakes are common (eg, southern and western United States and Mexico) [<a href="#rid34">34</a>].</p><p>Treatment of any suspected Crotalinae snakebite should proceed based on signs and symptoms irrespective of the snake species [<a href="#rid10">10</a>]. Thus, definitive identification of the biting snake is <strong>not</strong> required to establish a diagnosis of envenomation.</p><p class="headingAnchor" id="H2869620913"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>In many patients, the diagnosis of a snakebite is obvious based upon clinical findings. For these patients, the key differential diagnosis is between bites by venomous (eg, Crotalinae) and nonvenomous snakes. Serious envenomation is established by the development of characteristic local or systemic effects after the bite. (See <a class="local">'Clinical manifestations'</a> above.)</p><p>When a snakebite is not obvious from the clinical presentation, sudden collapse, syncope, unexplained hematologic abnormalities (eg, thrombocytopenia, hypofibrinogenemia, and/or coagulopathy), developing descending flaccid paralysis (rare), or rhabdomyolysis (rare) should raise the possibility of Crotalinae snakebite within a wider set of differential diagnoses. In addition, a patient stating that they have suffered a snakebite may potentially present with clinical features that could have other etiologies that might become apparent after further evaluation:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other hematologic disease with coagulopathy or bleeding</strong> – Sepsis, multiple trauma, obstetrical complications, or malignancy may present with similar hematologic features to snake envenomation, but are readily distinguished by clinical findings (eg, the presence of fever and signs of infection [eg, pneumonia, urinary tract infection, and/or petechiae] in patients with sepsis, evidence of multiple trauma, or known or suspected malignancy). (See  <a class="medical medical_review" href="/z/d/html/1306.html" rel="external">"Evaluation and management of disseminated intravascular coagulation (DIC) in adults"</a>.)</p><p></p><p class="bulletIndent1">Bleeding may also be caused by a wide array of other disease states, including hereditary abnormalities of the hemostasis system (eg, hemophilia or von Willebrand disease). Of note, mild variants of such congenital abnormalities are an important underlying cause for unexplained, minor changes in coagulation tests in a snakebite patient who otherwise shows no evidence of significant envenomation. In many instances, a careful history and physical examination and more rigorous laboratory testing can define the underlying cause. (See  <a class="medical medical_review" href="/z/d/html/5936.html" rel="external">"Approach to the child with bleeding symptoms"</a> and  <a class="medical medical_review" href="/z/d/html/1367.html" rel="external">"Approach to the adult with a suspected bleeding disorder"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rhabdomyolysis</strong> – Rhabdomyolysis may be caused by other disease states. The causes of rhabdomyolysis can be broadly divided into three categories:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Traumatic or muscle compression (eg, crush syndrome or prolonged immobilization)</p><p class="bulletIndent2"><span class="glyph">•</span>Nontraumatic exertional (eg, marked exercise, hyperthermia, or metabolic myopathies)</p><p class="bulletIndent2"><span class="glyph">•</span>Nontraumatic nonexertional (eg, drugs or toxins such as snake venoms, infections, or electrolyte disorders)</p><p></p><p class="bulletIndent1">In most instances, rhabdomyolysis caused by snakebite is associated with pain and local swelling and thus is readily distinguished from other causes. The causes of rhabdomyolysis and its diagnosis are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/16414.html" rel="external">"Rhabdomyolysis: Epidemiology and etiology"</a> and  <a class="medical medical_review" href="/z/d/html/5169.html" rel="external">"Rhabdomyolysis: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute weakness and paralysis (Mohave or Southern Pacific rattlesnake bite)</strong> – Toxic encounters in addition to snakebites that may cause flaccid paralysis include paralytic tick envenomation, paralytic shellfish poisoning, nicotine poisoning (ingestion or dermal exposure), or botulism. In most instances, history of a snakebite and fang marks will rapidly distinguish these rattlesnake bites from other toxic conditions.</p><p></p><p class="bulletIndent1">Additional differentiating features include the following:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Tick paralysis typically has a slower onset of weakness and may present with ataxia or localized facial or extremity paralysis. Tick paralysis is diagnosed by finding an attached argasid or ixodid tick. (See  <a class="medical medical_review" href="/z/d/html/7900.html" rel="external">"Tick paralysis", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Food history including ingestion of shellfish (especially noncommercially harvested bivalve mollusks) or home-canned foods helps to identify paralytic shellfish poisoning or foodborne botulism, respectively. (See  <a class="medical medical_review" href="/z/d/html/2745.html" rel="external">"Overview of shellfish, pufferfish, and other marine toxin poisoning", section on 'Paralytic shellfish poisoning'</a> and  <a class="medical medical_review" href="/z/d/html/5509.html" rel="external">"Botulism", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Secondary muscarinic symptoms (eg, salivation, lacrimation, vomiting, diarrhea, wheezing, diaphoresis, small pupils) and primary nicotinic signs (eg, tachycardia, hypertension, and seizures) suggest nicotine poisoning. (See  <a class="medical medical_review" href="/z/d/html/6507.html" rel="external">"Potentially toxic plant ingestions in children: Clinical manifestations and evaluation", section on 'Nicotinic poisoning'</a>.)</p><p></p><p class="bulletIndent1">The approach to acquired muscle weakness caused by other medical illness (eg, myasthenia gravis or demyelinating disease) is described separately. (See  <a class="medical medical_review" href="/z/d/html/5155.html" rel="external">"Approach to the patient with muscle weakness"</a> and  <a class="medical medical_review" href="/z/d/html/6442.html" rel="external">"Etiology and evaluation of the child with weakness"</a> and  <a class="medical medical_review" href="/z/d/html/294.html" rel="external">"Evaluation of the adult with acute weakness in the emergency department"</a>.)</p><p></p><p class="headingAnchor" id="H25"><span class="h1">ADDITIONAL RESOURCES</span></p><p class="headingAnchor" id="H3171505941"><span class="h2">Regional poison control centers</span><span class="headingEndMark"> — </span>Regional poison control centers in the United States are available at all times for consultation on patients with known or suspected poisoning and who may be critically ill, require admission, or have clinical pictures that are unclear (1-800-222-1222). In addition, some hospitals have medical toxicologists available for bedside consultation. Whenever available, these are invaluable resources to help in the diagnosis and management of ingestions or overdoses. Contact information for poison centers around the world is provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/138307.html" rel="external">"Society guideline links: Regional poison control centers"</a>.)</p><p class="headingAnchor" id="H863556578"><span class="h2">Society guideline links</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/112692.html" rel="external">"Society guideline links: Envenomation by snakes, arthropods (spiders and scorpions), and marine animals"</a>.)</p><p class="headingAnchor" id="H26"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medically important snakes</strong> – Rattlesnakes (<em>Crotalus</em> and <em>Sistrurus</em> species)  (<a class="graphic graphic_picture graphicRef122492" href="/z/d/graphic/122492.html" rel="external">picture 1</a>), water moccasins (cottonmouths; <em>Agkistrodon piscivorus</em>)  (<a class="graphic graphic_picture graphicRef122490" href="/z/d/graphic/122490.html" rel="external">picture 2</a>), and copperheads (<em>Agkistrodon contortrix</em>)  (<a class="graphic graphic_picture graphicRef122491" href="/z/d/graphic/122491.html" rel="external">picture 3</a>)<em> </em>are members of the family Viperidae, subfamily Crotalinae (formerly Crotalidae) and represent the most common medically important snakes found in North America  (<a class="graphic graphic_table graphicRef122086" href="/z/d/graphic/122086.html" rel="external">table 1</a>). They are also commonly called pit vipers, a name that refers to the heat-sensing pits located behind their nostrils. (See <a class="local">'Terminology'</a> above.)</p><p></p><p class="bulletIndent1">Among venomous snakes, copperheads, rattlesnakes, and water moccasins (cottonmouths) account for the most snakebites in the United States. These snakes are also found in southern Canada and Mexico. (See <a class="local">'Epidemiology'</a> above and <a class="local">'Appearance and geographical distribution'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Symptomatic Crotalinae (rattlesnake, water moccasin [cottonmouth], or copperhead) envenomation typically causes swelling, local tissue damage with ecchymosis, and hematologic toxicity. Other potential sequelae include vomiting, diarrhea, oral paresthesias, an unusual metallic taste, shock, bleeding, rhabdomyolysis, angioedema with cardiovascular collapse, myokymia, or neuromuscular weakness (typically after bites by the Mohave or Southern Pacific rattlesnake). (See <a class="local">'Clinical manifestations'</a> above and <a class="local">'Venom properties'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – Clinical evaluation of Crotalinae snakebites begins with emergency stabilization of any systemic effects (eg, hypotension, bleeding, altered mental status, or, for bites to the face or neck, upper airway obstruction) followed by an assessment of the wound site and local adjacent tissues. Determining presence of envenomation is essential to guide further management  (<a class="graphic graphic_algorithm graphicRef138360" href="/z/d/graphic/138360.html" rel="external">algorithm 1</a>). (See <a class="local">'Evaluation'</a> above.)</p><p></p><p class="bulletIndent1">Signs of envenomation include (see <a class="local">'Physical examination'</a> above):</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Presence of fang marks  (<a class="graphic graphic_picture graphicRef122493" href="/z/d/graphic/122493.html" rel="external">picture 4</a> and <a class="graphic graphic_picture graphicRef122494" href="/z/d/graphic/122494.html" rel="external">picture 5</a> and <a class="graphic graphic_picture graphicRef122500" href="/z/d/graphic/122500.html" rel="external">picture 6</a> and <a class="graphic graphic_picture graphicRef122499" href="/z/d/graphic/122499.html" rel="external">picture 12</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Redness, swelling, blistering, ecchymosis, persistent blood ooze, or tissue necrosis at the bite site  (<a class="graphic graphic_picture graphicRef122497" href="/z/d/graphic/122497.html" rel="external">picture 7</a> and <a class="graphic graphic_picture graphicRef73921" href="/z/d/graphic/73921.html" rel="external">picture 8</a> and <a class="graphic graphic_picture graphicRef122496" href="/z/d/graphic/122496.html" rel="external">picture 9</a> and <a class="graphic graphic_picture graphicRef122495" href="/z/d/graphic/122495.html" rel="external">picture 10</a> and <a class="graphic graphic_picture graphicRef122498" href="/z/d/graphic/122498.html" rel="external">picture 11</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Progression of swelling, using demarcation of the extent of swelling from the bite site for reference during repeated examinations  (<a class="graphic graphic_picture graphicRef122497" href="/z/d/graphic/122497.html" rel="external">picture 7</a>) or, if a leading edge of swelling is not evident, repeated measurement of extremity circumference both proximal and distal to the bite site. Proximal redistribution of edema resulting from limb elevation alone does not constitute progression of swelling.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bleeding other than at the bite site (eg, epistaxis, bleeding from gums, or oozing at needle puncture sites), hypotension, anaphylaxis, myokymia (rippling muscle movement often seen in the face), or, rarely, weakness. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Ancillary studies</strong> – Initial laboratory studies after a suspected Crotalinae snakebite include (see <a class="local">'Ancillary studies'</a> above):</p><p></p><p class="bulletIndent1">All patients:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Complete blood count</p><p class="bulletIndent2"><span class="glyph">•</span>Fibrinogen level</p><p class="bulletIndent2"><span class="glyph">•</span>Prothrombin time (PT) </p><p class="bulletIndent2"><span class="glyph">•</span>International normalized ratio (INR)</p><p></p><p class="bulletIndent1">Patients with evidence of systemic toxicity should also have the following studies obtained: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Serum electrolytes, creatinine and blood urea nitrogen</p><p class="bulletIndent2"><span class="glyph">•</span>Serum creatine kinase (CK)</p><p class="bulletIndent2"><span class="glyph">•</span>Chest radiograph</p><p class="bulletIndent2"><span class="glyph">•</span>Electrocardiogram (ECG)</p><p></p><p class="bulletIndent1">Concern for compartment syndrome or neurotoxicity:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Serum CK</p><p></p><p class="bulletIndent1">Hemotoxicity (prolonged PT, thrombocytopenia, or hypofibrinogenemia) may not be apparent at presentation but can develop over several hours after the snakebite.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Reassessment</strong> – Frequent, repeated examinations are important to ensure detection of all signs of Crotalinae snake envenomation and to identify serious and progressive local or systemic effects. All patients with a potentially toxic snakebite warrant frequent measurement of blood pressure and continuous cardiorespiratory and pulse oximetry monitoring. (See <a class="local">'Reassessment'</a> above.)</p><p></p><p class="bulletIndent1">Hematologic studies and blood chemistries should be repeated according to the severity of the envenomation. (See  <a class="medical medical_review" href="/z/d/html/121865.html" rel="external">"Bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) in the United States: Management", section on 'Initial stabilization'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diagnosis</strong> – The diagnosis of bites by Crotalinae snakes (rattlesnakes, water moccasins [cottonmouths], or copperheads) is usually straightforward because the bite is immediately felt and a snake is seen. The presence of fang marks, pain, and local effects of swelling, ecchymosis, and blistering, or evidence of systemic envenomation provide confirmation. Definitive identification of the biting snake is <strong>not</strong> required to establish a diagnosis of a Crotalinae snakebite. (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="bulletIndent1">The clinician should also maintain a high index of suspicion for a Crotalinae snakebite when evaluating presentations of abrupt onset of irritability (young children), unilateral extremity swelling, cardiovascular collapse, and/or neurologic impairment, especially in regions where venomous snakebites are common (eg, southern and western United States and northern and central Mexico). (See <a class="local">'Diagnosis'</a> above.)</p><p></p><p class="headingAnchor" id="H3296547241"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>We are saddened by the death of Steven A Seifert, MD, FAACT, FACMT, who passed away in May 2022. UpToDate gratefully acknowledges Dr. Seifert's outstanding work as an author for this topic.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Seifert SA, Boyer LV, Benson BE, Rogers JJ. AAPCC database characterization of native U.S. venomous snake exposures, 2001-2005. Clin Toxicol (Phila) 2009; 47:327.</a></li><li><a class="nounderline abstract_t">Schulte J, Domanski K, Smith EA, et al. Childhood victims of snakebites:  2000-2013. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Ruha AM, Kleinschmidt KC, Greene S, et al. The Epidemiology, Clinical Course, and Management of Snakebites in the North American Snakebite Registry. J Med Toxicol 2017; 13:309.</a></li><li><a class="nounderline abstract_t">Corbett B, Clark RF. North American Snake Envenomation. Emerg Med Clin North Am 2017; 35:339.</a></li><li><a class="nounderline abstract_t">Schulte J, Domanski K, Smith EA, et al. Childhood Victims of Snakebites: 2000-2013. Pediatrics 2016; 138.</a></li><li><a class="nounderline abstract_t">Gold BS, Dart RC, Barish RA. Bites of venomous snakes. N Engl J Med 2002; 347:347.</a></li><li><a class="nounderline abstract_t">Phillips C, Lipman GS, Gugelmann H, et al. Snakebites and climate change in California, 1997-2017. Clin Toxicol (Phila) 2019; 57:168.</a></li><li><a class="nounderline abstract_t">Casewell NR, Jackson TNW, Laustsen AH, Sunagar K. Causes and Consequences of Snake Venom Variation. Trends Pharmacol Sci 2020; 41:570.</a></li><li><a class="nounderline abstract_t">Casewell NR, Wagstaff SC, Wüster W, et al. Medically important differences in snake venom composition are dictated by distinct postgenomic mechanisms. Proc Natl Acad Sci U S A 2014; 111:9205.</a></li><li><a class="nounderline abstract_t">Lavonas EJ, Ruha AM, Banner W, et al. Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop. BMC Emerg Med 2011; 11:2.</a></li><li><a class="nounderline abstract_t">Kitchens CS, Hunter S, Van Mierop LH. Severe myonecrosis in a fatal case of envenomation by the canebrake rattlesnake (Crotalus horridus atricaudatus). Toxicon 1987; 25:455.</a></li><li><a class="nounderline abstract_t">Carroll RR, Hall EL, Kitchens CS. Canebrake rattlesnake envenomation. Ann Emerg Med 1997; 30:45.</a></li><li><a class="nounderline abstract_t">Jansen PW, Perkin RM, Van Stralen D. Mojave rattlesnake envenomation: prolonged neurotoxicity and rhabdomyolysis. Ann Emerg Med 1992; 21:322.</a></li><li><a class="nounderline abstract_t">Wills BK, Billet M, Rose SR, et al. Prevalence of hematologic toxicity from copperhead envenomation: an observational study. Clin Toxicol (Phila) 2020; 58:262.</a></li><li><a class="nounderline abstract_t">Levine M, Ruha AM, Padilla-Jones A, et al. Bleeding following rattlesnake envenomation in patients with preenvenomation use of antiplatelet or anticoagulant medications. Acad Emerg Med 2014; 21:301.</a></li><li><a class="nounderline abstract_t">White J. Snake venoms and coagulopathy. Toxicon 2005; 45:951.</a></li><li><a class="nounderline abstract_t">Hogan DE, Dire DJ. Anaphylactic shock secondary to rattlesnake bite. Ann Emerg Med 1990; 19:814.</a></li><li><a class="nounderline abstract_t">Tanen DA, Ruha AM, Graeme KA, et al. Rattlesnake envenomations: unusual case presentations. Arch Intern Med 2001; 161:474.</a></li><li><a class="nounderline abstract_t">Péterfi O, Boda F, Szabó Z, et al. Hypotensive Snake Venom Components-A Mini-Review. Molecules 2019; 24.</a></li><li><a class="nounderline abstract_t">Menezes TN, Naumann GB, Peixoto P, et al. Bothrops leucurus venom induces acute hypotension in rats by means of its phospholipase A2 (blD-PLA2). Toxicon 2020; 185:5.</a></li><li><a class="nounderline abstract_t">Richardson WH, Goto CS, Gutglass DJ, et al. Rattlesnake envenomation with neurotoxicity refractory to treatment with crotaline Fab antivenom. Clin Toxicol (Phila) 2007; 45:472.</a></li><li><a class="nounderline abstract_t">Clark RF, Williams SR, Nordt SP, Boyer-Hassen LV. Successful treatment of crotalid-induced neurotoxicity with a new polyspecific crotalid Fab antivenom. Ann Emerg Med 1997; 30:54.</a></li><li><a class="nounderline abstract_t">Levine M, Tashman D, Recchio I, et al. Neurotoxicity Associated With the Southern Pacific Rattlesnake (Crotalushelleri). Ann Emerg Med 2023; 81:318.</a></li><li><a class="nounderline abstract_t">Brick JF, Gutmann L, Brick J, et al. Timber rattlesnake venom-induced myokymia: evidence for peripheral nerve origin. Neurology 1987; 37:1545.</a></li><li><a class="nounderline abstract_t">LoVecchio F, Pizon AF, Wallace KL, Kunkel DB. Myokymia after snake envenomation in Arizona. Wilderness Environ Med 2005; 16:116.</a></li><li><a class="nounderline abstract_t">Vohra R, Cantrell FL, Williams SR. Fasciculations after rattlesnake envenomations: a retrospective statewide poison control system study. Clin Toxicol (Phila) 2008; 46:117.</a></li><li><a class="nounderline abstract_t">Heise CW, Cunningham C, Ruha AM, O'Connor AD. One Bite, Two Patients: Disparate Clinical Courses Following Simultaneous Crotalus oreganus abyssus Envenomation. Wilderness Environ Med 2020; 31:354.</a></li><li><a class="nounderline abstract_t">Bush SP, Siedenburg E. Neurotoxicity associated with suspected southern Pacific rattlesnake (Crotalus viridis helleri) envenomation. Wilderness Environ Med 1999; 10:247.</a></li><li><a class="nounderline abstract_t">French WJ, Hayes WK, Bush SP, et al. Mojave toxin in venom of Crotalus helleri (Southern Pacific Rattlesnake): molecular and geographic characterization. Toxicon 2004; 44:781.</a></li><li><a class="nounderline abstract_t">Farstad D, Thomas T, Chow T, et al. Mojave rattlesnake envenomation in southern California: a review of suspected cases. Wilderness Environ Med 1997; 8:89.</a></li><li><a class="nounderline abstract_t">Hayes WK, Corbit AG, Cardwell MD, Herbert SS. Interfang Distances of Rattlesnakes: Sexual, Interspecific, and Body Size-related Variation, and Implications for Snakebite Research and Management. Wilderness Environ Med 2017; 28:101.</a></li><li><a class="nounderline abstract_t">Heise CW, Ruha AM, Padilla-Jones A, et al. Clinical predictors of tissue necrosis following rattlesnake envenomation. Clin Toxicol (Phila) 2018; 56:281.</a></li><li><a class="nounderline abstract_t">Ali AJ, Horwitz DA, Mullins ME. Lack of coagulopathy after copperhead snakebites. Ann Emerg Med 2015; 65:404.</a></li><li><a class="nounderline abstract_t">Norris RL, Wilkerson JA, Feldman J. Syncope, massive aspiration, and sudden death following rattlesnake bite. Wilderness Environ Med 2007; 18:206.</a></li></ol></div><div id="topicVersionRevision">Topic 6595 Version 56.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19514880" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : AAPCC database characterization of native U.S. venomous snake exposures, 2001-2005.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Childhood victims of snakebites:  2000-2013</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28975491" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : The Epidemiology, Clinical Course, and Management of Snakebites in the North American Snakebite Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28411931" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : North American Snake Envenomation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27940763" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Childhood Victims of Snakebites: 2000-2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12151473" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Bites of venomous snakes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30180761" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Snakebites and climate change in California, 1997-2017.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32564899" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Causes and Consequences of Snake Venom Variation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24927555" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Medically important differences in snake venom composition are dictated by distinct postgenomic mechanisms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21291549" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Unified treatment algorithm for the management of crotaline snakebite in the United States: results of an evidence-informed consensus workshop.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3617084" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Severe myonecrosis in a fatal case of envenomation by the canebrake rattlesnake (Crotalus horridus atricaudatus).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9209224" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Canebrake rattlesnake envenomation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1536496" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Mojave rattlesnake envenomation: prolonged neurotoxicity and rhabdomyolysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31342795" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Prevalence of hematologic toxicity from copperhead envenomation: an observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24628755" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Bleeding following rattlesnake envenomation in patients with preenvenomation use of antiplatelet or anticoagulant medications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15922768" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Snake venoms and coagulopathy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2389865" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Anaphylactic shock secondary to rattlesnake bite.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11176775" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Rattlesnake envenomations: unusual case presentations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31370142" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Hypotensive Snake Venom Components-A Mini-Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32569848" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Bothrops leucurus venom induces acute hypotension in rats by means of its phospholipase A2 (blD-PLA2).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17503249" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Rattlesnake envenomation with neurotoxicity refractory to treatment with crotaline Fab antivenom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9209226" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Successful treatment of crotalid-induced neurotoxicity with a new polyspecific crotalid Fab antivenom.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36253294" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Neurotoxicity Associated With the Southern Pacific Rattlesnake (Crotalushelleri).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3627455" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Timber rattlesnake venom-induced myokymia: evidence for peripheral nerve origin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15974263" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Myokymia after snake envenomation in Arizona.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18259958" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Fasciculations after rattlesnake envenomations: a retrospective statewide poison control system study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32826164" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : One Bite, Two Patients: Disparate Clinical Courses Following Simultaneous Crotalus oreganus abyssus Envenomation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10628285" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Neurotoxicity associated with suspected southern Pacific rattlesnake (Crotalus viridis helleri) envenomation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15500854" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Mojave toxin in venom of Crotalus helleri (Southern Pacific Rattlesnake): molecular and geographic characterization.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11990148" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Mojave rattlesnake envenomation in southern California: a review of suspected cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28483391" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Interfang Distances of Rattlesnakes: Sexual, Interspecific, and Body Size-related Variation, and Implications for Snakebite Research and Management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28885114" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Clinical predictors of tissue necrosis following rattlesnake envenomation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25199611" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Lack of coagulopathy after copperhead snakebites.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17896845" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Syncope, massive aspiration, and sudden death following rattlesnake bite.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
